09:08:09 EDT Sat 20 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for Sept. 9, 2016

2016-09-09 20:32 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange fell 13.44 points to 812.16 Friday but ended the week up 1.24 points. Roger Dent's halted capital pool shell, Quinsam Opportunities I Inc. (QOP), has added a nominee to the board of directors of its resulting issuer. For its qualifying transaction, the shell is acquiring VitalHub Corp., the creator of a mobile app called VitalHub Chart. The app enables health care providers to access patient data on a cellphone or tablet. Quinsam Opportunities, which has nine million shares issued, will issue 13,400,016 shares to VitalHub's shareholders. Currently, the shell is selling a $500,000 private placement of 4,545,454 units at 11 cents through Industrial Alliance Securities Inc.

The new director nominee is Barry Tissenbaum, an accountant in Toronto. He was a partner at Ernst & Young LLP from 1991 to 2005. From April, 2006, to October, 2015, Mr. Tissenbaum was a director of Medworxx Solutions Inc., the designer of a patient flow management program for hospitals. Medworxx was acquired by private U.S. software company Aptean Inc. in October, 2015, for 56.56 cents cash per share. Mr. Tissenbaum was also a director of Northstar Healthcare Inc. (now called Nobilis Health Corp. (NHC: $4.38)), Universal Energy Group Ltd. (now a part of Just Energy Group Inc. (JE: $7.22)) and private Canadian software company Corel Corp. These days, he is a trustee of Noranda Income Fund (NIF: $2.65).

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed